Abstract:

Abstract:Objective To approach the efficacy and safety of  arotinolol in treating essential hypertension. Methods The studies about arotinolol in treating essential hypertension were  accessed by searching the Cochrane Central Register of Controlled Trials(Issue 3，2008)，MEDLINE(1991 to March 2009)，EMbase(1991 to March 2009)，CBMdisc(1991 to March 2009)，and CNKI(1994 to March 2009)．The relevant journals and conference proceedings also hand searched．Randomized controlled trials (RCTs) in which arotinolol was used to treat patients with essential hypertension were collected．Then   the retrieved studies according to predefined inclusion and exclusion criteria were screened，the quality of included studies was evaluated，and Meta analysis was performed by using RevMan 4.2 software． Results A total of 176 articles were found and 6 of which were finally included.In homogeneity test：χ2=4.41，df=7，P=0.73(efficacy)；χ2=2.96，df=4，P=0.56 (safety).In combined test，Z=0.64（P=0.52），OR=1.17，OR95％CI (0.72-1.85) (efficacy)；Z=1.75（P=0.08），OR=0.60，OR95％CI (0.34-1.06) (safety).Conclusion There is no significant difference in efficacy and safety between arotinolol and control group in treating essential hypertension.

Key words: arotinolol;almarl； hypertension；Mata analysis
〖BF〗〖LM〗